Recent 8-K filings for MOBI

• August 11, 2026, 4:12 PM ET earnings materiality 0.80 negative item 2.02item 9.01

  Mobia Medical Q2 revenue $13.5M (+102% YoY), net loss $21.0M; FY26 guide $54-56M

  Revenue $13.5M vs $6.7M in Q2 2025, up 102%; gross margin 83.2% vs 82.3%.

• August 3, 2026, 5:20 PM ET leadership materiality 0.50 neutral item 5.02 ◈ executive_change

  Mobia Medical appoints Dr. Myriam Curet to board of directors

  Board expanded from 7 to 8 members; Dr. Curet appointed as Class II director effective July 30, 2026.

• July 15, 2026, 4:11 PM ET leadership materiality 0.35 neutral item 5.02

  Mobia Medical appoints Reza Zadno, Ph.D. to board, expands to 7 members

  Board increased from 6 to 7; Dr. Zadno appointed as Class III director, term through 2029 annual meeting.

• May 11, 2026, 5:29 PM ET other material materiality 1.00 positive item 5.03item 9.01 ◈ Governance Changes ×2

  Mobia Medical completes IPO, adopts amended charter with classified board and exclusive forum provisions

  IPO closed May 11, 2026; authorized common stock increased to 950M shares; 50M shares of undesignated preferred stock authorized.

Executive changes

Materiality & sentiment trend

Max materiality 1.00 · Median 0.65 · Most common event leadership

1 positive 1 negative 2 neutral

source · MOBI on sec.gov